Mark Gudesblatt Selected Research

Therapeutics

7/2022	Dimethyl fumarate is associated with lower rates of infection and lower infection-related healthcare costs when compared with ocrelizumab.
3/2020	Multiple Sclerosis: Clinical Updates in Women's Health Care Primary and Preventive Care Review.
1/2017	Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.
7/2016	Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
7/2016	NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.
9/2014	First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Gudesblatt Research Topics

Disease

11	Multiple Sclerosis 01/2022 - 05/2011
3	Relapsing-Remitting Multiple Sclerosis 12/2020 - 04/2020
2	Chorea (Rheumatic Chorea) 01/2017 - 07/2016
2	Huntington Disease (Huntington's Disease) 01/2017 - 07/2016
2	Fatigue 07/2016 - 01/2013
2	Stroke (Strokes) 11/2015 - 09/2014
2	Peroneal Neuropathies 11/2015 - 09/2014
2	Parkinson Disease (Parkinson's Disease) 04/2006 - 07/2004
1	Infections 07/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Lymphopenia (Lymphocytopenia) 04/2020
1	Psychomotor Agitation (Akathisia) 07/2016
1	Sleepiness 07/2016
1	Dyskinesias (Dyskinesia) 07/2004

Drug/Important Bio-Agent (IBA)

5	Natalizumab (Tysabri)FDA Link 04/2020 - 01/2013
4	Dimethyl FumarateIBA 07/2022 - 04/2020
3	diroximel fumarateIBA 01/2022 - 11/2020
3	FumaratesIBA 01/2022 - 11/2020
2	deutetrabenazineIBA 01/2017 - 07/2016
1	ocrelizumabIBA 07/2022
1	ibudilastIBA 01/2021
1	Amantadine (Aman)FDA LinkGeneric 01/2019
1	Tetrabenazine (Nitoman)FDA Link 01/2017
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 07/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 09/2014
1	Baclofen FDA LinkGeneric 05/2011
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 04/2006
1	Levodopa (L Dopa)FDA LinkGeneric 07/2004

Therapy/Procedure

6	Therapeutics 07/2022 - 09/2014
2	Foot Orthoses 11/2015 - 09/2014
1	Activities of Daily Living (ADL) 09/2014
1	Injections 09/2014
1	Deep Brain Stimulation 07/2004
1	Electrodes (Electrode) 07/2004